EUVIMEDEUVIMED entdecken
LeserbriefOpen Access

Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma

Lilly Gu, Erica Lin, Shuaitong Liu, Ning Yang, Nicholas Kurtansky, Neil M Neumann, Joseph Stoll, Cecilia Lezcano, Melissa Pulitzer, Sarah Noor, Alina Markova, Anthony Rossi und 2 weitere

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28396 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Lilly Gu und 13 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA. Hauptthemen laut MEDLINE: Sarcoma, Kaposi, Sexual and Gender Minorities, Skin Neoplasms, HIV Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple treatment modalities for Kaposi sarcoma (KS) have been reported, including chemotherapy, radiation therapy, surgical excision, electrochemotherapy, and cryotherapy. Common topical treatments include timolol, imiquimod, and alitretinoin. We searched our institutional database for patients with ICD‐9 or 10 codes for KS seen by a dermatologist with experience in KS management from July 1, 2004 to January 1, 2022. We screened patient charts to include patients who received combination therapy of cryotherapy followed by topical imiquimod three times a week for 2 months ( n = 9). Patients were followed in the clinic every 3 months. Time to resolution was assessed by photographic evidence of resolution as determined by a dermatologist and corroborated with clinical documentation in patient charts. Median age (IQR) at KS diagnosis was 58 (27.5) years. All patients were male ( n = 9, 100%). Majority were white ( n = 7, 78%) and non‐Hispanic ( n = 8, 89%). Five (56%) had classic KS, one (11%) had HIV‐associated KS, and three (33%) were HIV‐negative men who have sex with men. Median time to resolution was 30.5 weeks, with a median of two treatments. In our study, 93% ( n = 42/45) of lesions and 89% ( n = 8/9) of patients experienced complete resolution during a median (range) duration of follow‐up of 58 (13–209) weeks. Side effects were limited to pain during cryotherapy, occasional blister formation after cryotherapy, and mild inflammation due to imiquimod. No infections were observed. Combination therapy of cryotherapy and topical imiquimod may be an efficacious and comparatively low‐risk treatment for limited, cutaneous KS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sarcoma, KaposiSexual and Gender MinoritiesSkin NeoplasmsHIV InfectionsHumansMaleMiddle AgedFemaleImiquimodHomosexuality, MaleCryotherapyImmunotherapy

Substanzen

Imiquimod

Autor:innen und Institutionen

  • Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Department of Dermatology, Weill Cornell Medical College, New York City, New York, USA.
  • Warren Alpert Medical School of Brown University, Providence, Rhode Island, USA.
  • Department of Pathology, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Department of Medicine, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.
  • Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York City, New York, USA.

ORCID-Profile: Liang Deng

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NIAMS NIH HHS

Zitieren

APA

Gu, L., Lin, E., Liu, S., Yang, N., Kurtansky, N., Neumann, N. M., Stoll, J., Lezcano, C., Pulitzer, M., Noor, S., Markova, A., Rossi, A., Dickson, M. A., & Deng, L. (2023). Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma. Journal of Medical Virology. https://doi.org/10.1002/jmv.28396

Vancouver

Gu L, Lin E, Liu S, Yang N, Kurtansky N, Neumann NM, et al. Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma. Journal of Medical Virology. 2023. doi:10.1002/jmv.28396

BibTeX
@article{Gu2023,
  author = {Gu, Lilly and Lin, Erica and Liu, Shuaitong and Yang, Ning and Kurtansky, Nicholas and Neumann, Neil M and Stoll, Joseph and Lezcano, Cecilia and Pulitzer, Melissa and Noor, Sarah and Markova, Alina and Rossi, Anthony and Dickson, Mark A and Deng, Liang},
  title = {Efficacy of immunotherapy with combination of cryotherapy and topical imiquimod for treatment of Kaposi sarcoma},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28396}
}
Kostenlos starten →